Marc Casper says the Ridgefield site, which specializes in fill‑finish and packaging of aseptic injectable medications, aligns with its plans to bolster U.S. capacity.
The company saw positive momentum in mammalian, bioconjugates, and small molecules, offsetting lower sales from its cell and gene therapy and microbial businesses.
CEO Pascal Soriot said the company’s capital expenditure will support its goal of reaching $80 billion in revenue by 2030, with 50% generated in the United States.
CEO Joaquin Duato told investors on Wednesday’s earnings call that the provisions of the law have “enabled” Johnson & Johnson’s commitment to invest $55 billion in the U.S.
Peter DeYoung, CEO of Piramal Global Pharma, says the geopolitical situation and trend toward onshoring “happens to be synergistic” with its investment in the United States.
A new survey from Unispace Life Sciences finds 57% of senior executives see the adoption of intelligent systems as critical to the next generation of laboratory environments.
The 200,000-square-foot facility will serve as a regional hub, offering increased production capacity and local support for pharmaceutical customers in Asia.
The company said it is expanding its cGMP manufacturing footprint and AI-powered development systems to strengthen domestic production of essential medicines.
Discover how automated calibration improves compliance, reduces human error, and increases efficiency in pharmaceutical manufacturing. This Beamex white paper explores the benefits...
Unlock the full potential of your GMP assets. Discover how life sciences organizations can optimize reliability, compliance, and performance with a data-driven approach to Asset...
Three of Cognite's chemical, refining, and energy customers take center stage in this product tour video that showcases why and how they are transforming their operations.
Are you making quick-enough progress on your industrial Gen AI journey? Learn what it actually takes to trust, deliver, and scale across operational use cases.
